Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$602.10 USD
-2.11 (-0.35%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $602.19 +0.09 (0.01%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Brokerage Reports
Thermo Fisher Scientific Inc. [TMO]
Reports for Purchase
Showing records 441 - 460 ( 550 total )
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Equity Research: Research Summary
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Encouraged by Sustained Momentum; Raising PT to $154
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Remain Constructive; Looking Through the Non-Operational Drags to EPS Guidance
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Industry: 4Q Earnings Preview; Results Likely in Line; Cautious Around 2016 Guidance
Provider: KEYBANC CAPITAL MARKETS
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Company: Thermo Fisher Scientific Inc.
Industry: Medical - Instruments
Good Strategic Fit and Accretive, but Small Relative to TMO
Provider: KEYBANC CAPITAL MARKETS